Today before the opening bell, International Stem Cell Corporation announced that an open letter to shareholders has been issued by Co-Chairman of the Board and Chief Executive Officer Andrey Semechkin PhD.
Addressing recent corporate governance and operational changes, the letter also provides an update on ISCO’s Research and Development accomplishments, challenges and 2012 – 2013 major milestones, and updates on both the Lifeline Skin Care’s and Lifeline Cell Technology’s initiatives.
The letter, in its entirety, can be found at the following link: http://www.internationalstemcell.com/2012_Shareholder_Letter
For additional information on ISCO, visit the company’s website at www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment